Logo image of SBBP

Strongbridge Bio Ord (SBBP) Stock News

NASDAQ:SBBP - Nasdaq -

2  +0.03 (+1.52%)

After market: 2.02 +0.02 (+1%)

SBBP Latest News, Press Relases and Analysis

News Image
3 years ago - Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.

DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”)...

News Image
3 years ago - Benzinga

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Mentions: MOR ZNTL ESPR ATNX ...

News Image
3 years ago - Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Xeris Pharmaceuticals (NASDAQ:XERS

Mentions: RMTI SNGX CMRX JAGX ...

News Image
4 years ago - Zacks Investment Research

Strongbridge Biopharma (SBBP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Strongbridge Biopharma (SBBP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.